PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ·Healthcare·Biotechnology
$1.06
-3.64%
Mkt Cap $76.79M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+371.7%
Consensus $5.00 vs current $1.06
NASDAQ·Healthcare·Biotechnology
$1.06
-3.64%
Mkt Cap $76.79M
No recent rating data.
Price Target (6 analysts)
$5.00
Range $5.00 – $5.00
+371.7%
Consensus $5.00 vs current $1.06